Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...

Investors were feeling zen on Wednesday, with no major news about Donald Trump's tariffs to worry about ahead of the monthly ...

MPS offers to cover part of SROs' salaries, training costs ahead of Feb. 17 deadline ...